Concepedia

Virginia L. Filiaci

VL

Statistics

Publications

37

Citations

5K

H-Index

28

Active since

2004

Affiliations

NRG Oncology(Current)

Roswell Park Comprehensive Cancer Center

Gynecologic Oncology Group

Memorial Sloan Kettering Cancer Center

University of Oklahoma Health Sciences Center

Virginia L. Filiaci is an author at NRG Oncology specializing in medicine, gynecologic oncology, and oncology.

ORCID

Publications per year

2004–2022

37

Publications

37

Randomized Phase III Trial of Whole-Abdominal Irradiation Versus Doxorubicin and Cisplatin Chemotherapy in Advanced Endometrial Carcinoma: A Gynecologic Oncology Group Study

Marcus E. Randall, Virginia L. Filiaci, Hyman B. Muss et al. · Journal of Clinical Oncology · 2005 · 870 citations · Full text

, , +10

Adjuvant Chemotherapy plus Radiation for Locally Advanced Endometrial Cancer

Daniela Matei, Virginia L. Filiaci, Marcus E. Randall et al. · New England Journal of Medicine · 2019 · 467 citations · Full text

, , +10

Carboplatin and Paclitaxel for Advanced Endometrial Cancer: Final Overall Survival and Adverse Event Analysis of a Phase III Trial (NRG Oncology/GOG0209)

David S. Miller, Virginia L. Filiaci, Robert S. Mannel et al. · Journal of Clinical Oncology · 2020 · 340 citations · Full text

, , +17

Phase III Trial: Adjuvant Pelvic Radiation Therapy Versus Vaginal Brachytherapy Plus Paclitaxel/Carboplatin in High-Intermediate and High-Risk Early-Stage Endometrial Cancer

Marcus E. Randall, Virginia L. Filiaci, D. Scott McMeekin et al. · Journal of Clinical Oncology · 2019 · 328 citations · Full text

, , +16

Phase III Trial of Ifosfamide With or Without Paclitaxel in Advanced Uterine Carcinosarcoma: A Gynecologic Oncology Group Study

Howard D. Homesley, Virginia L. Filiaci, Maurie Markman et al. · Journal of Clinical Oncology · 2007 · 262 citations · Full text

, , +10

1–5 of 37